Please login to the form below

Not currently logged in
Email:
Password:

obintuzumab

This page shows the latest obintuzumab news and features for those working in and with pharma, biotech and healthcare.

Roche signs biologics partnership with Samsung

Roche signs biologics partnership with Samsung

In addition, the company has 39 investigational biologic medicines in its pipeline, the most advanced of which is chronic lymphocytic leukaemia candidate obintuzumab.

Latest news

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics